To test whether SRSF1 could regulate the alternative splicing of CD44 in GC cells, as it was reported in breast cancer cells [18], we detected the relative levels of different CD44 isoforms in MGC-803 cells transfected with siRNA specific to SRSF1 or negative control (Fig. 5a). This evidence concerns the gene CD44 and breast carcinoma.